Table 3.
Association of the COVID-19 and mortality
| Variables | Coefficients | 95% clearance | Significance |
|---|---|---|---|
| Age | 0.051 | 0.02-0.08 | 0.0005 |
| Men | 4.12 | 1.4-6.90 | 0.00010 |
| SOB | 2.80 | 1.0-4.61 | 0.0021 |
| HT | 6.97 | 3.3-10.7 | 0.0002 |
| DM | 7.21 | 1.4-173.99 | 0.006 |
| Chills | 5.80 | 2.8-8.91 | 0.00020 |
| Fatigue | 2.50 | 0.5-4.50 | 0.01 |
| Pyrexia | 2.90 | 0.2-5.70 | 0.04 |
| Cough | 2.10 | 0.2-4.11 | 0.03 |
| Kidney injury | 14.40 | 9.0-19.80 | <0.0001 |
| Pneumonia | 11.70 | 5.9-17.50 | <0.00010 |
| Malaise | 2.70 | 0.7-4.80 | 0.0097 |
| Diarrhea | 3.40 | 0.01-6.90 | 0.051 |
| Heart failure | 6.20 | 2.3-10.11 | 0.0021 |
| ARDS | 6.10 | 4.5-7.60 | <0.0001 |
| Shock | 23.30 | 13.7-32.90 | <0.0001 |
| Respiratory failure | 2.50 | 0.4-4.60 | 0.021 |
| TWBC (g/L) | 0.30 | 0.07-0.60 | 0.010 |
| ALT (U/L) | 0.060 | 0.01-0.100 | 0.010 |
| Total bilirubin (µmol/L) | 0.20 | 0.01-0.40 | 0.040 |
| Lymphocyte count (g/L) | −ymph | −ymphocyte | 0.0010 |
| AST (U/L) | 0.030 | 0.01-0.050 | 0.002 |
| Albumin (g/L) | −lbum | −lbumin (g | <0.0001 |
| LDH (U/L) | 0.010 | 0.00-0.002 | 0.007 |
| Procalcitonin (ng/mL) | 2.10 | 0.7-3.50 | 0.0041 |
| NC (g/L) | 0.50 | 0.3-0.80 | <0.0001 |
| Creatinine (μmol/L) | 0.030 | 0.01-0.050 | 0.0005 |
| CRP (mg/L) | 0.040 | 0.02-0.051 | <0.0001 |
| BUN (mmol/L) | 0.40 | 0.09-0.60 | 0.009 |
| CK (U/L) | −K (U/ | −K (U/L) 0/L)μ | 0.0032 |
| PT (s) | 0.40 | 0.01-0.80 | 0.041 |
| Antibiotic usage | 4.10 | 2.9-5.40 | <0.0001 |
| Corticosteroids usage | 4.30 | 2.6-6.11 | <0.0001 |
| IgG | 2.60 | 0.7-6.40 | 0.010 |
| ICU | 4.10 | 2.0-7.21 | ≤0.0001 |
HT: Hypertension, DM: Diabetes mellitus, CRP: C-reactive protein, SOB: Shortness of breath, ALT: Alanine aminotransferase, TWBC: Total white blood cell counts, AST: Aspartate aminotransferase, LDH: Lactic dehydrogenase, BUN: Blood urea nitrogen, PT: Prothrombin time, IgG: Immunoglobulin G, NC: Neutrophil count, ICU: Intensive care unit, CK: Creatine kinase